MELANOMA
INDICATION FOR USE
MELANOMA
HOW TO MEASURE
THE EIS TECHNOLOGY
CLINICAL STUDIES
CLINICAL BENEFITS
RESEARCH MILESTONES
PUBLICATIONS
PATIENT LESION CARDS
FOR PATIENTS
SKIN CANCER INFORMATION
FIND CLINICS
SELF EXAMINATION
PATIENT ORGANIZATIONS
PATIENT LABELING
SCIBASE
ABOUT SCIBASE
AVAILABLE MARKETS
WE ARE SCIBASE
NEWS & EVENTS
CEO-LETTERS
AVAILABLE MATERIALS
FINANCIAL INFORMATION
CONTACT
INVESTORS
CONTACT US
The only FDA approved point-of-care technology for detection of melanoma
Atlantic Derm Conference 2019
